{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:00:01Z","timestamp":1782741601338,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Umea University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In this study, we aimed to evaluate the prognostic significance of collagens in patients with oral squamous cell carcinoma (OSCC). Plasma proteomics data from 40 OSCC patients and 33 healthy controls, generated using the Olink Explore 3072 platform, along with microarray gene expression data from 29 OSCC tumours, 21 clinically normal tissues contralateral to tumour (NTCT), and 14 healthy controls, were analysed to assess expression levels of collagens and their associations with clinicopathological variables and survival outcomes. Eleven collagen peptides were detected in plasma. Higher circulating levels of collagen type III alpha 1 chain (COL3A1) propeptides were associated with improved overall survival and longer disease-free time (p\u2009&lt;\u20090.05). Penalised Cox regression using the least absolute shrinkage and selection operator (LASSO) supported COL3A1 propeptide as a survival-associated feature. Comparison of protein profiles between COL3A1-low and COL3A1-high patients identified neutrophil degranulation as the most significantly enriched pathway. Microarray differential expression analysis showed COL3A1 mRNA to be significantly upregulated in tumour tissues compared with NTCT and healthy controls (FDR\u2009&lt;\u20090.05). Circulating COL3A1 propeptide shows potential as a prognostic biomarker for OSCC and may reflect systemic immune-related alterations.<\/jats:p>","DOI":"10.1038\/s41598-026-57329-0","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:08:05Z","timestamp":1782738485000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma COL3A1 propeptide as a promising prognostic marker in oral squamous cell carcinoma"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6546-7642","authenticated-orcid":false,"given":"Mustafa","family":"Magan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolian","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Sgaramella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Nylander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"57329_CR1","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/medsci11020042","volume":"11","author":"A Barsouk","year":"2023","unstructured":"Barsouk, A., Aluru, J. S., Rawla, P., Saginala, K. & Barsouk, A. Epidemiology, risk factors, and prevention of head and neck squamous cell carcinoma. Med. Sci. (Basel). 11, 42. https:\/\/doi.org\/10.3390\/medsci11020042 (2023).","journal-title":"Med. Sci. (Basel)"},{"key":"57329_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/bs.acr.2021.05.002","volume":"152","author":"GR Bhat","year":"2021","unstructured":"Bhat, G. R., Hyole, R. G. & Li, J. Head and neck cancer: current challenges and future perspectives. Adv. Cancer Res. 152, 67\u2013102. https:\/\/doi.org\/10.1016\/bs.acr.2021.05.002 (2021).","journal-title":"Adv. Cancer Res."},{"key":"57329_CR3","doi-asserted-by":"publisher","first-page":"155489","DOI":"10.1016\/j.prp.2024.155489","volume":"261","author":"D Jagadeesan","year":"2024","unstructured":"Jagadeesan, D. et al. Comprehensive insights into oral squamous cell carcinoma: diagnosis, pathogenesis, and therapeutic advances. Pathol. Res. Pract. 261, 155489. https:\/\/doi.org\/10.1016\/j.prp.2024.155489 (2024).","journal-title":"Pathol. Res. Pract."},{"key":"57329_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.oraloncology.2008.06.002","volume":"45","author":"S Warnakulasuriya","year":"2009","unstructured":"Warnakulasuriya, S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 45, 309\u2013316. https:\/\/doi.org\/10.1016\/j.oraloncology.2008.06.002 (2009).","journal-title":"Oral Oncol."},{"key":"57329_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","volume":"6","author":"DE Johnson","year":"2020","unstructured":"Johnson, D. E. et al. Head and neck squamous cell carcinoma. Nat. Rev. Dis. Primers. 6, 92. https:\/\/doi.org\/10.1038\/s41572-020-00224-3 (2020).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"57329_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101426","volume":"21","author":"B Goel","year":"2022","unstructured":"Goel, B. et al. Therapeutic approaches for the treatment of head and neck squamous cell carcinoma\u2014an update on clinical trials. Transl. Oncol. 21, 101426, 101426. https:\/\/doi.org\/10.1016\/j.tranon.2022.101426 (2022).","journal-title":"Transl. Oncol."},{"key":"57329_CR7","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/j.annonc.2020.07.011","volume":"31","author":"JP Machiels","year":"2020","unstructured":"Machiels, J. P. et al. Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 31, 1462\u20131475. https:\/\/doi.org\/10.1016\/j.annonc.2020.07.011 (2020).","journal-title":"Ann. Oncol."},{"issue":"18","key":"57329_CR8","doi-asserted-by":"publisher","first-page":"8844","DOI":"10.3390\/ijms26188844","volume":"26","author":"S Vyhn\u00e1nkov\u00e1","year":"2025","unstructured":"Vyhn\u00e1nkov\u00e1, S. et al. Cold, hot, and lethal\u2014the tumour microenvironment and the immunology of head and neck squamous cell carcinoma. Int. J. Mol. Sci. 268844, 8844. https:\/\/doi.org\/10.3390\/ijms26188844 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"57329_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12943-019-0983-5","volume":"18","author":"B Peltanova","year":"2019","unstructured":"Peltanova, B., Raudenska, M. & Masarik, M. Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review. Mol. Cancer. 18, 63. https:\/\/doi.org\/10.1186\/s12943-019-0983-5 (2019).","journal-title":"Mol. Cancer"},{"key":"57329_CR10","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1016\/j.yexcr.2011.05.023","volume":"317","author":"J Dud\u00e1s","year":"2011","unstructured":"Dud\u00e1s, J. et al. Tumor-produced active interleukin-1\u03b2 regulates gene expression in carcinoma-associated fibroblasts. Exp. Cell Res. 317, 2222\u20132229. https:\/\/doi.org\/10.1016\/j.yexcr.2011.05.023 (2011).","journal-title":"Exp. Cell Res."},{"issue":"4","key":"57329_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3892\/or.2024.8800","volume":"52","author":"CA Shirima","year":"2024","unstructured":"Shirima, C. A. et al. Epithelial\u2011derived head and neck squamous tumourigenesis (Review). Oncol. Rep. 52141, 141. https:\/\/doi.org\/10.3892\/or.2024.8800 (2024).","journal-title":"Oncol. Rep."},{"issue":"1","key":"57329_CR12","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41392-021-00641-0","volume":"6","author":"F Wu","year":"2021","unstructured":"Wu, F. et al. Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer. Signal Transduct. Target. Ther. 6218, 218. https:\/\/doi.org\/10.1038\/s41392-021-00641-0 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"57329_CR13","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.3390\/jpm13111616","volume":"13","author":"E Jumaniyazova","year":"2023","unstructured":"Jumaniyazova, E., Lokhonina, A., Dzhalilova, D., Kosyreva, A. & Fatkhudinov, T. Role of microenvironmental components in head and neck squamous cell carcinoma. J. Pers. Med. 13, 1616. https:\/\/doi.org\/10.3390\/jpm13111616 (2023).","journal-title":"J. Pers. Med."},{"key":"57329_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41568-020-00329-7","volume":"21","author":"TR Cox","year":"2021","unstructured":"Cox, T. R. The matrix in cancer. Nat Rev Cancer 21, 217\u2013238 (2021).","journal-title":"Nat Rev Cancer"},{"key":"57329_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41568-020-00329-7","volume":"38","author":"NI Nissen","year":"2019","unstructured":"Nissen, N. I., Karsdal, M. & Willumsen, N. Collagens and cancer-associated fibroblasts in the reactive stroma and its relation to cancer biology. J. Exp. Clin. Cancer Res. 38, 115, 115. https:\/\/doi.org\/10.1038\/s41568-020-00329-7 (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"57329_CR16","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","volume":"11","author":"J Winkler","year":"2020","unstructured":"Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J. & Werb, Z. Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat. Commun. 115120, 5120. https:\/\/doi.org\/10.1038\/s41467-020-18794-x (2020).","journal-title":"Nat. Commun."},{"key":"57329_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/jbmr.5650080202","volume":"8","author":"EF Eriksen","year":"1993","unstructured":"Eriksen, E. F. et al. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J Bone Miner Res 8, 127\u2013132. https:\/\/doi.org\/10.1002\/jbmr.5650080202 (1993).","journal-title":"J Bone Miner Res"},{"key":"57329_CR18","doi-asserted-by":"publisher","first-page":"30599","DOI":"10.1038\/srep30599","volume":"6","author":"SN Kehlet","year":"2016","unstructured":"Kehlet, S. N. et al. Excessive collagen turnover products are released during colorectal cancer progression and elevated in serum from metastatic colorectal cancer patients. Sci. Rep. 6, 30599. https:\/\/doi.org\/10.1038\/srep30599 (2016).","journal-title":"Sci. Rep."},{"key":"57329_CR19","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1002\/ijc.31627","volume":"143","author":"A Lipton","year":"2018","unstructured":"Lipton, A. et al. High turnover of extracellular matrix reflected by specific protein fragments measured in serum is associated with poor outcomes in two metastatic breast cancer cohorts. Int. J. Cancer 143, 3027\u20133034. https:\/\/doi.org\/10.1002\/ijc.31627 (2018).","journal-title":"Int. J. Cancer"},{"key":"57329_CR20","doi-asserted-by":"publisher","first-page":"19761","DOI":"10.1038\/s41598-019-56268-3","volume":"9","author":"N Willumsen","year":"2019","unstructured":"Willumsen, N. et al. Collagen fragments quantified in serum as measures of desmoplasia associate with survival outcome in patients with advanced pancreatic cancer. Sci. Rep. 9, 19761. https:\/\/doi.org\/10.1038\/s41598-019-56268-3 (2019).","journal-title":"Sci. Rep."},{"key":"57329_CR21","doi-asserted-by":"publisher","first-page":"12415","DOI":"10.3390\/ijms232012415","volume":"23","author":"L Necula","year":"2022","unstructured":"Necula, L. et al. Collagen family as promising biomarkers and therapeutic targets in cancer. Int. J. Mol. Sci. 23, 12415. https:\/\/doi.org\/10.3390\/ijms232012415 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"57329_CR22","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/cjp2.138","volume":"5","author":"X Gu","year":"2019","unstructured":"Gu, X. et al. High immune cytolytic activity in tumor-free tongue tissue confers better prognosis in patients with squamous cell carcinoma of the oral tongue. J. Pathol. Clin. Res. 5, 240\u2013247. https:\/\/doi.org\/10.1002\/cjp2.138 (2019).","journal-title":"J. Pathol. Clin. Res."},{"key":"57329_CR23","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/jop.70020","volume":"54","author":"X Gu","year":"2025","unstructured":"Gu, X. et al. A unique plasma protein signature characterizes squamous cell carcinoma of the oral tongue in young adults. J. Oral Pathol. Med. 54, 706\u2013714. https:\/\/doi.org\/10.1111\/jop.70020 (2025).","journal-title":"J. Oral Pathol. Med."},{"key":"57329_CR24","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform. 14, 128. https:\/\/doi.org\/10.1186\/1471-2105-14-128 (2013).","journal-title":"BMC Bioinform."},{"key":"57329_CR25","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90\u2013W97. https:\/\/doi.org\/10.1093\/nar\/gkw377 (2016).","journal-title":"Nucleic Acids Res."},{"key":"57329_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.90","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie, Z. et al. Gene set knowledge discovery with Enrichr. Curr. Protoc. 1, e90. https:\/\/doi.org\/10.1002\/cpz1.90 (2021).","journal-title":"Curr. Protoc."},{"key":"57329_CR27","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1002\/ijc.32751","volume":"146","author":"IM Chen","year":"2020","unstructured":"Chen, I. M. et al. Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer. Int. J. Cancer 146, 2913\u20132922. https:\/\/doi.org\/10.1002\/ijc.32751 (2020).","journal-title":"Int. J. Cancer"},{"key":"57329_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001193","volume":"8","author":"DP Hurkmans","year":"2020","unstructured":"Hurkmans, D. P. et al. Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma. J. Immunother. Cancer 8, e001193. https:\/\/doi.org\/10.1136\/jitc-2020-001193 (2020).","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"57329_CR29","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/s41598-020-79608-0","volume":"11","author":"NI Nissen","year":"2021","unstructured":"Nissen, N. I. et al. Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab. Sci. Rep. 11865, 865. https:\/\/doi.org\/10.1038\/s41598-020-79608-0 (2021).","journal-title":"Sci. Rep."},{"key":"57329_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.gene.2019.05.003","volume":"707","author":"H Kuivaniemi","year":"2019","unstructured":"Kuivaniemi, H. & Tromp, G. Type III collagen (COL3A1): gene and protein structure, tissue distribution, and associated diseases. Gene 707, 151\u2013171. https:\/\/doi.org\/10.1016\/j.gene.2019.05.003 (2019).","journal-title":"Gene"},{"key":"57329_CR31","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.oraloncology.2011.09.002","volume":"48","author":"S Nurmenniemi","year":"2012","unstructured":"Nurmenniemi, S. et al. Type I and III collagen degradation products in serum predict patient survival in head and neck squamous cell carcinoma. Oral Oncol. 48, 136\u2013140. https:\/\/doi.org\/10.1016\/j.oraloncology.2011.09.002 (2012).","journal-title":"Oral Oncol."},{"key":"57329_CR32","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00392-012-0440-6","volume":"101","author":"HR Neuberger","year":"2012","unstructured":"Neuberger, H. R. et al. Procollagen propeptides: serum markers for atrial fibrosis? Clin. Res. Cardiol. 101, 655\u2013661. https:\/\/doi.org\/10.1007\/s00392-012-0440-6 (2012).","journal-title":"Clin. Res. Cardiol."},{"key":"57329_CR33","first-page":"619","volume":"5","author":"G Piecha","year":"2013","unstructured":"Piecha, G. et al. The neo-epitope specific PRO-C3 ELISA measures true formation of type III collagen associated with liver and muscle parameters. Am. J. Transl Res. 5, 619\u2013630 (2013). https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3633973","journal-title":"Am. J. Transl Res."},{"key":"57329_CR34","doi-asserted-by":"publisher","first-page":"e0219528","DOI":"10.1371\/journal.pone.0219526","volume":"14","author":"D Junker","year":"2019","unstructured":"Junker, D. et al. Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cART. PLoS One. 14, e0219528. https:\/\/doi.org\/10.1371\/journal.pone.0219526 (2019).","journal-title":"PLoS One"},{"key":"57329_CR35","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3390\/cancers13040654","volume":"13","author":"SH Kang","year":"2021","unstructured":"Kang, S. H. et al. Cancer-associated fibroblast subgroups showing differential promoting effect on HNSCC progression. Cancers (Basel). 13, 654. https:\/\/doi.org\/10.3390\/cancers13040654 (2021).","journal-title":"Cancers (Basel)"},{"key":"57329_CR36","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1158\/2326-6066.cir-15-0017","volume":"3","author":"JE Glogauer","year":"2015","unstructured":"Glogauer, J. E., Sun, C. X., Bradley, G. & Magalhaes, M. A. Neutrophils increase oral squamous cell carcinoma invasion through an invadopodia-dependent pathway. Cancer Immunol. Res. 3, 1218\u20131226. https:\/\/doi.org\/10.1158\/2326-6066.cir-15-0017 (2015).","journal-title":"Cancer Immunol. Res."},{"key":"57329_CR37","doi-asserted-by":"publisher","first-page":"29047","DOI":"10.18632\/oncotarget.25540","volume":"9","author":"JE Glogauer","year":"2018","unstructured":"Glogauer, J. E., Sun, C. X., Bradley, G. & Magalhaes, M. A. O. Oral inflammation promotes oral squamous cell carcinoma invasion. Oncotarget 9, 29047\u201329063. https:\/\/doi.org\/10.18632\/oncotarget.25540 (2018).","journal-title":"Oncotarget"},{"key":"57329_CR38","doi-asserted-by":"publisher","first-page":"812044","DOI":"10.3389\/fonc.2022.812044","volume":"12","author":"X Hu","year":"2022","unstructured":"Hu, X. et al. Neutrophils promote tumor progression in oral squamous cell carcinoma by regulating EMT and JAK2\/STAT3 signaling through chemerin. Front. Oncol. 12, 812044. https:\/\/doi.org\/10.3389\/fonc.2022.812044 (2022).","journal-title":"Front. Oncol."},{"key":"57329_CR39","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41420-024-01982-9","volume":"10","author":"R Zhai","year":"2024","unstructured":"Zhai, R. et al. Neutrophil extracellular traps promote invasion and metastasis via NLRP3-mediated oral squamous cell carcinoma pyroptosis inhibition. Cell. Death Discov. 10, 214. https:\/\/doi.org\/10.1038\/s41420-024-01982-9 (2024).","journal-title":"Cell. Death Discov"},{"key":"57329_CR40","doi-asserted-by":"publisher","first-page":"1046974","DOI":"10.3389\/fonc.2022.1046974","volume":"12","author":"J Akhtar","year":"2022","unstructured":"Akhtar, J. et al. Quantitative tissue proteome profile reveals neutrophil degranulation and remodeling of extracellular matrix proteins in early stage gallbladder cancer. Front. Oncol. 12, 1046974. https:\/\/doi.org\/10.3389\/fonc.2022.1046974 (2022).","journal-title":"Front. Oncol."},{"issue":"17","key":"57329_CR41","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.3390\/cancers17172770","volume":"17","author":"K Takabatake","year":"2025","unstructured":"Takabatake, K. et al. Refining the role of tumor-associated macrophages in oral squamous cell carcinoma. Cancers 172770, 2770. https:\/\/doi.org\/10.3390\/cancers17172770 (2025).","journal-title":"Cancers"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57329-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57329-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57329-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:29:11Z","timestamp":1782739751000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57329-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["57329"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-57329-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"22 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The studies were approved by the Regional Ethical Review Board in Ume\u00e5, Sweden (Dnr 03-201; 08\u2009\u2212\u2009003\u00a0M; 2012-131-33\u00a0M and 2014-193-32\u00a0M). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"19773"}}